TY  - JOUR
AU  - Palladino, Claudia
AU  - Sanchez-Carrillo, Marta
AU  - Mate-Cano, Irene
AU  - Vazquez-Moron, Sonia
AU  - Jimenez-Sousa, Maria Angeles
AU  - Gutiirrez-Rivas, Monica
AU  - Resino, Salvador
AU  - Briz, Veronica
PY  - 2017
DO  - 10.1038/s41598-017-02968-7
SN  - 2045-2322
UR  - http://hdl.handle.net/20.500.12105/7337
AB  - Relevant resistance-associated substitutions (RASs) to elbasvir, the new HCV NS5A inhibitor, may limit its efficacy and lead to virological failure in HCV-GT1a-infected patients. There are few data outside clinical trials evaluating their prevalence...
LA  - eng
PB  - Nature Publishing Group
KW  - Benzofurans
KW  - Cross-Sectional Studies
KW  - Female
KW  - Hepacivirus
KW  - Hepatitis C
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Middle Aged
KW  - Spain
KW  - Viral Nonstructural Proteins
KW  - Drug Resistance, Viral
KW  - Genotype
TI  - Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study
TY  - journal article
ER  -